In a recent article for Life Science Leader, Rob Wright shared some insights following a meeting with Kim Bush, a Bill & Melinda Gates Foundation representative. “Personally, I have been very impressed with how the foundation has turned the ailing pharma R&D program upside down, spearheading innovative projects that most pharma and bio companies would… Continue Reading